It was founded in 2024 by Aja Beckett, a software engineer who was herself a GLP-1 patient, and the product reflects that practical perspective
Bridge was initially intended to run for six months, but it has since been extended by 18 months because the Medicare BALANCE model was delayed indefinitely (see below)
While the core patent in India expires in March 2026, the US patent was granted a Patent Term Extension (PTE) that pushes exclusivity to December 2031
Some studies have raised concerns that GLP-1 receptor agonists like Ozempic may increase the risk of pancreatic inflammation, which could contribute to the development of cancer
If your plan technically covers GLP-1 drugs and you were denied improperly, your insurer ignored medical evidence, or you have exhausted appeals and still face denial, it could be time to speak with an attorney
If you need to lose 10-15% of your body weight and want the most established option, semaglutide is the clear choice